{"transactions":[{"id":1798320,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":110289,"kind":"person","name":"Lin Celia","position":1,"cik":"0001859386","reported_name":"Lin Celia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-23T21:59:56.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":1490,"price":16.6547,"value":24815.503,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on September 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.83, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11010,"source":{"system":"sec-edgar","filing":"0001209191-23-047105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123047105/doc4.xml","form_type":"4"}},{"id":2006255,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":110289,"kind":"person","name":"Lin Celia","position":1,"cik":"0001859386","reported_name":"Lin Celia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T21:08:19.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":7.87,"expiration_date":"2033-02-14","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-010510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123010510/doc4.xml","form_type":"4"}},{"id":2175685,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":110289,"kind":"person","name":"Lin Celia","position":1,"cik":"0001859386","reported_name":"Lin Celia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:11:00.000Z","date":"2022-08-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under Issuer's 2021 Equity Incentive Plan.  One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-22-047170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047170/doc4.xml","form_type":"4"}},{"id":2384608,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":110289,"kind":"person","name":"Lin Celia","position":1,"cik":"0001859386","reported_name":"Lin Celia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-18T21:11:25.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":52412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 16, 2022, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":52412,"derivative":{"exercise_price":20.94,"expiration_date":"2032-02-15","underlying":"Class A Common Stock","underlying_shares":52412},"source":{"system":"sec-edgar","filing":"0001209191-22-011222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122011222/doc4.xml","form_type":"4"}},{"id":2709815,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":110289,"kind":"person","name":"Lin Celia","position":1,"cik":"0001859386","reported_name":"Lin Celia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T00:33:26.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":16916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":16916,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":16916},"source":{"system":"sec-edgar","filing":"0001209191-21-033334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919121033334/doc4.xml","form_type":"4"}}]}